Document is current
Any future updates will be listed below
-
Authors
Yang, Seonkyeong
Knox, Caitlin https://orcid.org/0000-0001-6870-2111
- License Information
-
More Information
Article History
Received: 15 December 2023
Accepted: 19 June 2024
First Online: 2 July 2024
Declarations
:
: This is a retrospective cohort study and was conducted using data from the Clinformatics<sup>®</sup> Data Mart database and therefore did not qualify/require Ethics Approval or consent to participate. All data analyzed during this study are from the Clinformatics Data Mart database that is cited in the Methods section. The study utilizes the secondary use of commercially available de-identified healthcare data. Identifiable patient information has been stripped and determined to be de-identified in accordance with the HIPAA Privacy Rule by either expert determination (§ 164.514 (b)(1)) or Safe Harbor (§ 164.514 (b)(2)). The use of data would not constitute human subjects research in accordance with the Common Rule (45 CFR 46.102(f)). Therefore, IRB review was not required.
: Not applicable.
: S.Y. conducted the analysis and writing as an intern and contractor for Regeneron Pharmaceuticals, Inc.C.K. is an employee of and shareholder in Regeneron Pharmaceuticals, Inc.
